Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise · 10b5-1 plan | M | $235K 2,207 sh | Aug 7, 2026 |
| 61 | Peck Michael DPRESIDENT | Open-market purchase | BUY | $1.50M 159.2K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 61 | Chad EisenbergTreasurer | Open-market purchase | BUY | $1.50M 54.2K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 61 | Peck Michael DPresident | Open-market purchase | BUY | $5.00M 180.8K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 58 | Chad EisenbergTREASURER | Open-market purchase | BUY | $400K 42.5K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 42 | Powell MaryDirector, Chief Executive Officer | Open-market sale | SELL | $316K 24.0K sh | Jul 7, 2026 traded Jul 6, 2026 |
| 39 | Loop PaulaDirector | Open-market sale · 10b5-1 plan | SELL | $1.00M 8,336 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 39 | Abajian DannyChief Financial Officer | Open-market sale | SELL | $218K 16.5K sh | Jul 7, 2026 traded Jul 6, 2026 |
| 39 | Steele JeannaChief Legal & People Officer | Open-market sale | SELL | $131K 9,897 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 38 | Thompson Travis AlvinChief Financial Officer | Open-market sale | SELL | $3,497 819 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 38 | Lee KevinDirector, CHIEF EXECUTIVE OFFICER | Open-market sale | SELL | $25K 5,905 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 38 | Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF | Open-market sale | SELL | $6,431 1,506 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 38 | Skynner MichaelCHIEF SCIENTIFIC OFFICER | Open-market sale | SELL | $7,938 1,859 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 37 | Kuang JinCFO | Open-market sale | SELL | $368 36.5K sh | Jul 7, 2026 traded Jun 29, 2026 |
| 36 | Giterman Arthur G.Director, CEO and CFO | Grant or award | A | $2.70M 7.09M sh | Jul 7, 2026 traded Jul 2, 2026 |
| 36 | Krause Allyson G.General Counsel | Grant or award | A | $1.01M 2.66M sh | Jul 7, 2026 traded Jul 2, 2026 |
| 36 | Barak MariaChief Accounting Officer | Open-market sale | SELL | $23K 1,747 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 36 | Liu YingDirector | Grant or award | A | — 123.8K sh | Jul 7, 2026 traded May 22, 2026 |
| 36 | Pao EllenDirector | Grant or award | A | — 123.8K sh | Jul 7, 2026 traded May 22, 2026 |
| 35 | Tang StanleyDirector | Open-market sale · 10b5-1 plan | SELL | $2.08M 10.8K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 33 | Solomon Lance I.Chief Product Officer | Grant or award | A | $442K 1.16M sh | Jul 7, 2026 traded Jul 2, 2026 |
| 33 | Strand Michael B.Chief Revenue Officer | Grant or award | A | $351K 923.7K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 33 | Carlson MeganCAO and SVP, Finance | Open-market sale | SELL | $329K 41.3K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 32 | Lee KevinDirector, CHIEF EXECUTIVE OFFICER | Open-market sale | SELL | $7,486 1,737 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 32 | Skynner MichaelCHIEF SCIENTIFIC OFFICER | Open-market sale | SELL | $2,293 532 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 32 | Tang StanleyDirector | Open-market sale · 10b5-1 plan | SELL | $387K 2,009 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 32 | Thompson Travis AlvinChief Financial Officer | Open-market sale | SELL | $448 104 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 32 | Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF | Open-market sale | SELL | $1,099 255 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 31 | Tang StanleyDirector | Open-market sale · 10b5-1 plan | SELL | $1.37M 7,206 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Robins Harlan SChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $3.30M 146.9K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Leung Lim Kin SimonDirector | Grant or award | A | $225K 592.1K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Lechleider RobertChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $377K 16.1K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Merle Denise MDirector | Grant or award | A | $150K 394.7K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Mendelson RobinDirector | Grant or award | A | $150K 394.7K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Robins Harlan SChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $5.20M 239.4K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Getz Joel A.Director | Grant or award | A | $150K 394.7K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 29 | Puylaert KevinChief Sales Officer | Open-market sale | SELL | $693 138 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 29 | Puylaert KevinChief Sales Officer | Open-market sale | SELL | $158 31 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 29 | Treseder Oluwadara JohnsonDirector | Open-market sale · 10b5-1 plan | SELL | $216K 1,875 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 29 | Sankar ShyamSee Remarks | Open-market sale · 10b5-1 plan | SELL | $19.50M 150.0K sh | Jul 7, 2026 traded Jul 2, 2026 |